Collecting patient payments is an ongoing struggle. Bills are confusing, reminders go missed and patients can’t always afford to pay. Rising self-pay costs, new medical debt mitigation regulations, Medicaid changes and staff shortages all put added pressure on billing teams. The result is often poor patient financial experiences, wasted staff time and bad debt. As…
Medicaid is under threat — again. Republicans, who narrowly control Congress, are pushing proposals that could sharply cut funding to the government health insurance program for poor and disabled Americans, as a way to finance President Donald Trump’s agenda for tax cuts and border security. Democrats, hoping to block the GOP’s plans and preserve Medicaid…
Texas is moving to allow for more freedom of choice with respect to receipt of vaccines. The Economist reports: Texas legislators meeting in Austin, the state capital, are debating new laws to relax vaccine rules, urged on by Texans for Vaccine Choice (TFVC). On February 18th activists in “Come and Make Me” shirts took to…
This year’s ViVE conference was full of announcements — from acquisitions to rebrands to product launches. This list compiles short summaries for seven of the conference’s most notable announcements. The post 7 ViVE Announcements You Don’t Want to Miss appeared first on MedCity News.
Millie’s Series A round was co-led by TMV and Foreground Capital. The financing will help the company expand its offerings and footprint. The post Millie Raises $12M to Advance Maternal Healthcare appeared first on MedCity News.
In an interview, VideaHealth CEO Florian Hillen says a new funding round will focus on enhancing customer service, expanding partnerships, and developing new AI-driven administrative tools
FibroGen secured regulatory approvals for roxadustat in China and Europe, but the FDA rejected the drug and asked for another clinical trial. By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication. The post AstraZeneca Secures China Rights to Anemia…
Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…
PEPFAR, the U.S. global HIV/AIDS program, is – for the first time in its two-decade history – facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.
[Sponsored] A webinar sponsored by Elation Health will offer insights and share tips on helping practices run more efficiently. It’s scheduled for Wednesday, February 26 at 3 pm ET. The post How Can Healthcare Practices Cut Waste? appeared first on MedCity News.